BMRN vs POCI · P/E 40, rev $1.76B vs rev $19.1M
Biomarin Pharmaceutical Inc (BMRN) versus Precision Optics Corporation, Inc. Common stock (POCI) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Precision Optics Corporation, Inc. Common stock (POCI) is a medical instruments & supplies company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported POCI revenue for 2025-06-30 was $19.1M. Net income was -$5.8M. POCI currently screens at market cap $63.4M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. POCI currently screens at market cap $63.4M.
Not investment advice. Open the BMRN and POCI stock pages for the full models.
Not investment advice.